CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsultation and Scientific Advisory Board Agreement • November 8th, 2018
as of November 8th, 2018 (the “Effective Date”), between Pyramidian Technology Group, Inc., having its principal place of business at 2645 Executive Park Drive, Weston FL 33331 “Company”), a Nevada corporation and Javier J. Canasi, M.D., practice located 3370 Burns Road, Suite 106 Palm Beach Gardens, FL 33410 (“Consultant”).
CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsultation and Scientific Advisory Board Agreement • March 11th, 2011 • Aveo Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS CONSULTING AND SCIENTIFIC ADVISORY BOARD AGREEMENT effective as of this 1ST day of January, 2010 (the “Effective Date”), between AVEO PHARMACEUTICALS, INC., a Delaware corporation with offices at 75 Sidney Street, 4th Floor, Cambridge, MA 02139 (the “Company”) and Lynda Chin, MD residing at 89 Hyslop Rd, Brookline, MA 02445 (“Consultant”).
CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsultation and Scientific Advisory Board Agreement • April 11th, 2012 • OvaScience, Inc. • Massachusetts
THIS CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (the “Agreement”), dated as of 7th Sept., 2011 (the “Effective Date”), is made between OVASCIENCE, Inc., a Delaware corporation, and its successors, subsidiaries and affiliates (collectively, the “Company”), and David Sinclair (“Consultant”).
CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENTConsultation and Scientific Advisory Board Agreement • April 11th, 2012 • OvaScience, Inc. • Massachusetts
THIS CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT (the “Agreement”), dated as of 13 July 2011 (the “Effective Date”), is made between OVASCIENCE, Inc., a Delaware corporation, and its successors, subsidiaries and affiliates (collectively, the “Company”), and Jonathan Tilly (“Consultant”).
EXHIBIT 10.4 CONSULTATION AND SCIENTIFIC ADVISORY BOARD AGREEMENT This Agreement, effective as of March 10, 1995, is between Inspire Pharmaceuticals, Inc. (the "Company"), a Delaware corporation, and Richard Boucher, M.D. ("Consultant"). W I T N E S S...Consultation and Scientific Advisory Board Agreement • February 25th, 2000 • Inspire Pharmaceuticals Inc • North Carolina
OvaScience, Inc.Consultation and Scientific Advisory Board Agreement • November 13th, 2013 • OvaScience, Inc. • Pharmaceutical preparations • Massachusetts
The purpose of this letter agreement (the “Agreement”) is to set forth the terms regarding your separation of employment from OvaScience, Inc. (the “Company”). As more fully set forth below, the Company desires to provide you with separation benefits in exchange for certain agreements by you. This Agreement shall become effective on the eighth (8th) day following your acceptance of it (the “Effective Date”) as described below.
